Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
49.27
+0.57 (1.17%)
At close: Jun 10, 2026, 4:00 PM EDT
48.48
-0.79 (-1.60%)
After-hours: Jun 10, 2026, 4:47 PM EDT

KNSA Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, KNSA stock has a consensus rating of "Strong Buy" and an average price target of $63.5. The average 1-year stock price forecast is 28.88% higher than the current stock price, while the lowest is $57 (+15.69%) and the highest is $72 (+46.13%).

Price Target: $63.5 (+28.88%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$57$63.5$62$72
Change+15.69%+28.88%+25.84%+46.13%
* Price targets were last updated on May 4, 2026.

Analyst Ratings

The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy667777
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total778888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$68$72
BuyMaintains$68$72+46.13%May 4, 2026
Wedbush
Wedbush
Buy
Maintains
$58$59
BuyMaintains$58$59+19.75%Apr 29, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$62$64
BuyReiterates$62$64+29.90%Apr 29, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$53$57
BuyMaintains$53$57+15.69%Apr 29, 2026
Citi
Citi
Buy
Maintains
$50$60
BuyMaintains$50$60+21.78%Apr 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
939.49M
from 677.56M
Increased by 38.66%
Revenue Next Year
1.13B
from 939.49M
Increased by 19.90%
EPS This Year
1.20
from 0.75
Increased by 60.00%
EPS Next Year
1.76
from 1.20
Increased by 46.46%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
38.54M220.18M270.26M423.24M677.56M939.49M
Revenue Growth
-471.24%22.75%56.61%60.09%38.66%
Gross Profit
28.61M173.21M180.33M234.02M370.35M834.03M
Gross Margin
74.22%78.67%66.72%55.29%54.66%88.78%
Operating Income
-156.64M9.77M-25.20M-45.62M77.22M137.89M
Net Income
-157.92M183.36M14.08M-43.19M59.01M101.23M
EPS
----0.751.20
EPS Growth
-----60.00%
Forward PE
---42.9327.3241.06
Free Cash Flow
-83.56M-2.36M13.79M22.57M97.89M117.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High945.1M
Avg939.5M
Low933.2M

Revenue Growth

Revenue Growth202620272028
High
39.5%
Avg
38.7%
Low
37.7%

EPS Forecast

EPS202620272028
High-
Avg1.20
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
60.0%
Low-